Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 · New England Journal of Medicine · 11K citations
https://doi.org/10.1056/nejmoa0905561
M
Michael D. Ezekowitz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
377
Papers
72.7K
Citations
91
h-index
220
i10-index
Michael D. Ezekowitz is an academic researcher from Thomas Jefferson University. The author has contributed to research in topics: Atrial Fibrillation Management and Outcomes & Cardiac Arrhythmias and Treatments & Antiplatelet Therapy and Cardiovascular Diseases. The author has an h-index of 91, co-authored 321 publications.
ORCID: 0000-0003-3623-2252Papers by this author
worksComparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 · The Lancet · 4,878 citations
https://doi.org/10.1016/s0140-6736(13)62343-0
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 · Circulation · 2,707 citations
https://doi.org/10.1161/cir.0000000000000665
Screening for Atrial Fibrillation
2017 · Circulation · 531 citations
https://doi.org/10.1161/circulationaha.116.026693
Electrocardiographic Early Repolarization
2016 · Circulation · 112 citations
https://doi.org/10.1161/cir.0000000000000388
Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trial
2016 · American Heart Journal · 33 citations
https://doi.org/10.1016/j.ahj.2016.06.008
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat